tiprankstipranks
Advertisement
Advertisement

AU:OSL Stock Latest News

OncoSil hits 100-patient milestone in key Spanish cancer market
Company AnnouncementsOncoSil hits 100-patient milestone in key Spanish cancer market
3h ago
OSL
OncoSil Medical Plans ASX Share Placement to Raise Capital
PremiumCompany Announcements
OncoSil Medical Plans ASX Share Placement to Raise Capital
20h ago
OSL
OncoSil Medical Raises $5.6m to Drive Cancer Device Commercialisation
PremiumCompany Announcements
OncoSil Medical Raises $5.6m to Drive Cancer Device Commercialisation
20h ago
OSL
OncoSil Seeks CMS Pass-Through Status to Support U.S. Launch of Cancer Device
PremiumCompany Announcements
OncoSil Seeks CMS Pass-Through Status to Support U.S. Launch of Cancer Device
6d ago
OSL
OncoSil Seeks US Medicare Pass-Through Status for Targeted Cancer Device
PremiumCompany Announcements
OncoSil Seeks US Medicare Pass-Through Status for Targeted Cancer Device
6d ago
OSL
OncoSil lodges updated ASX corporate governance statement for FY 2026
PremiumCompany AnnouncementsOncoSil lodges updated ASX corporate governance statement for FY 2026
11d ago
OSL
OncoSil narrows annual loss as revenue and other income surge
Premium
Company Announcements
OncoSil narrows annual loss as revenue and other income surge
11d ago
OSL
OncoSil Seeks ASX Quotation for Small Issue of New Shares
Premium
Company Announcements
OncoSil Seeks ASX Quotation for Small Issue of New Shares
22d ago
OSL
OncoSil Flags FDA Milestone While Stressing Investor Caution
PremiumCompany Announcements
OncoSil Flags FDA Milestone While Stressing Investor Caution
22d ago
OSL
OncoSil Wins Landmark U.S. FDA Approval for Rare Bile Duct Cancer Device
PremiumCompany Announcements
OncoSil Wins Landmark U.S. FDA Approval for Rare Bile Duct Cancer Device
22d ago
OSL
OncoSil Medical Posts Strong FY26 Growth as Pancreatic Cancer Device Gains Regulatory and Clinical Traction
PremiumCompany Announcements
OncoSil Medical Posts Strong FY26 Growth as Pancreatic Cancer Device Gains Regulatory and Clinical Traction
1M ago
OSL
OncoSil Study Backs Higher-Concentration Formulations to Boost Efficiency
PremiumCompany Announcements
OncoSil Study Backs Higher-Concentration Formulations to Boost Efficiency
2M ago
OSL
OncoSil Medical Lists Additional Ordinary Shares on ASX
PremiumCompany AnnouncementsOncoSil Medical Lists Additional Ordinary Shares on ASX
2M ago
OSL
OncoSil Highlights Financial Position and Niche Cancer Device Focus
Premium
Company Announcements
OncoSil Highlights Financial Position and Niche Cancer Device Focus
2M ago
OSL
OncoSil to Showcase Real-World Pancreatic Cancer Data at Major Nuclear Medicine Congress
Premium
Company Announcements
OncoSil to Showcase Real-World Pancreatic Cancer Data at Major Nuclear Medicine Congress
2M ago
OSL
OncoSil validates scalable Australian manufacturing for pancreatic cancer device
PremiumCompany Announcements
OncoSil validates scalable Australian manufacturing for pancreatic cancer device
2M ago
OSL
OncoSil trial data at ESMO GI 2026 bolster case for FOLFIRINOX label expansion
PremiumCompany Announcements
OncoSil trial data at ESMO GI 2026 bolster case for FOLFIRINOX label expansion
2M ago
OSL
OncoSil Seeks First U.S. Approval With FDA Filing for Cancer Device
PremiumCompany Announcements
OncoSil Seeks First U.S. Approval With FDA Filing for Cancer Device
2M ago
OSL
OncoSil Joins EU PALACROS Consortium With Cost-Efficient Pancreatic Cancer Trial
PremiumCompany Announcements
OncoSil Joins EU PALACROS Consortium With Cost-Efficient Pancreatic Cancer Trial
2M ago
OSL
OncoSil trial data wins ESMO GI spotlight with promising pancreatic cancer results
PremiumCompany AnnouncementsOncoSil trial data wins ESMO GI spotlight with promising pancreatic cancer results
2M ago
OSL
OncoSil to Release 41,067 Escrowed Shares Issued as Director Fees
Premium
Company Announcements
OncoSil to Release 41,067 Escrowed Shares Issued as Director Fees
2M ago
OSL
OncoSil flags FDA progress and early TRIPP-FFX data in investor update
Premium
Company Announcements
OncoSil flags FDA progress and early TRIPP-FFX data in investor update
3M ago
OSL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >